TORONTO, Jan. 22, 2020 /CNW/ – Liberty Health Sciences Inc. (CSE: LHS) (OTCQX: LHSIF)www.libertyhealthsciences.com (“Liberty” or the “Company”), a provider of high quality cannabis announced today that it has partnered with iHeartJane (“Jane”) www.iheartjane.com, the leading eCommerce platform for dispensaries and brands in the U.S., to offer a seamless retail shopping experience for Liberty patients who order products on the Company’s website at a dispensary level.
Liberty now displays its product availability and pricing in real-time on an easy-to-use online ordering platform empowering patients to shop for their favorite brands from their favorite local Liberty dispensary. Currently the service allows patients to reserve their products for pick-up only.
“Liberty remains the gold standard for customer experiences centered around convenience and Jane allows us to set ourselves apart in providing our patients with a variety of integrated technologies that makes their life easier while enjoying our products,” said Victor Mancebo, Interim Chief Executive Officer of Liberty. “Jane is a fully automated solution that live-streams all of our products in real-time so our patients will know 100 percent of the time where and when their product is available for pickup. Establishing such a solid platform for our customers is pivotal to our overall growth.”
Jane is the cannabis industry’s first fully automated e-commerce solution, powering 1,300+ dispensaries and brands across 28 state markets. Jane provides dispensaries and brands with a turnkey eCommerce solution, including real-time POS integration, curated content directly from the brands (the best pictures, descriptions, etc.), and retail and market analytics.
“Jane is excited to be partnering with Liberty and supporting their continued growth throughout Florida. As Liberty continues to bring an exceptional selection of products across the state, we look forward to enabling a best-in-class omnichannel shopping experience for their patients,” said Socrates Rosenfeld, co-founder and CEO of Jane.
About Liberty Health Sciences Inc.
Liberty is the cannabis provider committed to providing a trusted, high quality cannabis experience based on our genuine care for all cannabis users and a focus on operational excellence from seed to sale. Liberty’s measured approach to expansion opportunities is focused on maximizing returns to shareholders, while keeping consumers’ well-being at the forefront of what we do. For more information, please visit: www.libertyhealthsciences.com.
CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS: This press release contains certain forward-looking statements within the meaning of applicable securities laws. Any statements that are contained in this news release that are not statements of historical fact may be deemed to be forward-looking statements. Forward-looking statements are often identified by terms such as “may”, “should”, “anticipate”, “expect”, “believe”, “plan”, “intend” or the negative of these terms and similar expressions. Forward-looking statements in this news release include, but are not limited to, expectations related to the Company’s production capabilities, expectations concerning the receipt of all necessary approvals from the Florida Department of Health, expectations concerning the opening of new dispensaries and the expansion of its greenhouse space, and the Company’s future expansion and growth strategies. Forward-looking statements necessarily involve known and unknown risks, including, without limitation, risks associated with general economic conditions; adverse industry events; marketing costs; loss of markets; future legislative and regulatory developments involving medical marijuana; inability to access sufficient capital from internal and external sources, and/or inability to access sufficient capital on favorable terms; the medical marijuana industry in the United States generally, income tax and regulatory matters; the ability of Liberty to implement its business strategies; competition; crop failure; currency and interest rate fluctuations and other risks. Readers are cautioned that the foregoing list is not exhaustive. Readers are further cautioned not to place undue reliance on forward-looking statements as there can be no assurance that the plans, intentions or expectations upon which they are placed will occur. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement.
SOURCE Liberty Health Sciences Inc.
For further information: Media Contacts: Dwain Schenck, (203) 223-5230, firstname.lastname@example.org; Victor Mancebo, Interim Chief Executive Officer, (386) 462-0141, VMancebo@libertyhealthsciences.com